Agreement of the HC2, Onclarity, and CLART assays on the detection of HPV in self-taken samples and cytology diagnoses from follow-up samples. Note that ≥ASCUS was determined on physician-taken follow-up samples by cytology, and the different denominators reflect the completeness of follow-up in each subgroup. (A) In total, 4,612 samples gave valid results on the Onclarity and CLART assays. Of these samples, 736 (16.0%) were positive by at least one of the two assays, and 609 (81%) of the women with positive results had a follow-up cytology registered. (B) In total, 964 samples gave valid results on all three assays (HC2, Onclarity, and CLART). Of these, 166 (17.2%) were positive by at least one of the assays, and 150 of the women with positive results (90.4%) had a follow-up cytology registered.